Free Trial

SNDL (SNDL) Competitors

SNDL logo
$1.65 -0.07 (-4.07%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$1.66 +0.02 (+0.91%)
As of 08/1/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SNDL vs. ACB, CGC, CRON, OGI, TLRY, EVO, JANX, EWTX, ABCL, and ANIP

Should you be buying SNDL stock or one of its competitors? The main competitors of SNDL include Aurora Cannabis (ACB), Canopy Growth (CGC), Cronos Group (CRON), Organigram Global (OGI), Tilray Brands (TLRY), Evotec (EVO), Janux Therapeutics (JANX), Edgewise Therapeutics (EWTX), AbCellera Biologics (ABCL), and ANI Pharmaceuticals (ANIP). These companies are all part of the "pharmaceutical products" industry.

SNDL vs. Its Competitors

Aurora Cannabis (NASDAQ:ACB) and SNDL (NASDAQ:SNDL) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, earnings, media sentiment, profitability, analyst recommendations, risk, institutional ownership and dividends.

Aurora Cannabis has higher earnings, but lower revenue than SNDL. SNDL is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aurora Cannabis$246.72M1.02$1.63M$0.1140.73
SNDL$671.81M0.65-$69.18M-$0.29-5.69

Aurora Cannabis has a net margin of 1.32% compared to SNDL's net margin of -10.38%. Aurora Cannabis' return on equity of 0.13% beat SNDL's return on equity.

Company Net Margins Return on Equity Return on Assets
Aurora Cannabis1.32% 0.13% 0.10%
SNDL -10.38%-8.47%-7.14%

Aurora Cannabis has a beta of 1.84, suggesting that its stock price is 84% more volatile than the S&P 500. Comparatively, SNDL has a beta of 3.57, suggesting that its stock price is 257% more volatile than the S&P 500.

47.6% of Aurora Cannabis shares are held by institutional investors. 0.0% of Aurora Cannabis shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

SNDL has a consensus target price of $4.00, suggesting a potential upside of 142.42%. Given SNDL's higher probable upside, analysts clearly believe SNDL is more favorable than Aurora Cannabis.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aurora Cannabis
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
2 Strong Buy rating(s)
3.67
SNDL
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, SNDL had 10 more articles in the media than Aurora Cannabis. MarketBeat recorded 12 mentions for SNDL and 2 mentions for Aurora Cannabis. SNDL's average media sentiment score of 0.86 beat Aurora Cannabis' score of 0.00 indicating that SNDL is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Aurora Cannabis
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
SNDL
5 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Aurora Cannabis beats SNDL on 12 of the 17 factors compared between the two stocks.

Get SNDL News Delivered to You Automatically

Sign up to receive the latest news and ratings for SNDL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SNDL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SNDL vs. The Competition

MetricSNDLMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$451.97M$10.40B$5.49B$9.52B
Dividend YieldN/A1.99%4.73%4.09%
P/E Ratio-6.1118.4228.7823.81
Price / Sales0.6529.01372.2066.04
Price / CashN/A22.3135.4557.96
Price / Book0.523.478.275.54
Net Income-$69.18M$234.77M$3.25B$259.28M
7 Day Performance8.91%-4.82%-3.70%-4.64%
1 Month Performance32.00%1.80%4.34%4.41%
1 Year Performance-21.80%-12.51%25.90%17.95%

SNDL Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SNDL
SNDL
2.6343 of 5 stars
$1.65
-4.1%
$4.00
+142.4%
-25.3%$451.97M$671.81M-6.112,516Trending News
Earnings Report
Analyst Revision
ACB
Aurora Cannabis
0.3762 of 5 stars
$4.78
-1.2%
N/A-26.0%$268.86M$343.29M43.451,130Upcoming Earnings
CGC
Canopy Growth
0.6272 of 5 stars
$1.09
-4.4%
N/A-84.5%$223.61M$225.65M-0.273,150News Coverage
Upcoming Earnings
CRON
Cronos Group
2.3244 of 5 stars
$2.06
+0.5%
N/A-17.0%$794.50M$117.61M15.85450News Coverage
Upcoming Earnings
OGI
Organigram Global
1.1589 of 5 stars
$1.48
-3.3%
N/A-15.3%$198.23M$117.47M14.80860News Coverage
TLRY
Tilray Brands
3.0503 of 5 stars
$0.70
+1.6%
$1.92
+173.9%
-71.4%$704.25M$210.48M-0.672,650Trending News
Earnings Report
Analyst Forecast
Insider Trade
Analyst Revision
Gap Down
EVO
Evotec
2.0865 of 5 stars
$4.26
flat
$5.93
+39.3%
-13.2%$1.51B$862.40M0.004,827News Coverage
JANX
Janux Therapeutics
2.4078 of 5 stars
$25.55
-1.6%
$91.89
+259.6%
-43.2%$1.51B$10.59M-18.7930Upcoming Earnings
EWTX
Edgewise Therapeutics
2.4487 of 5 stars
$14.26
+1.0%
$40.00
+180.5%
-14.6%$1.50BN/A-9.2060News Coverage
Upcoming Earnings
Analyst Forecast
ABCL
AbCellera Biologics
2.4221 of 5 stars
$4.92
-3.7%
$8.75
+77.8%
+39.0%$1.47B$28.83M-8.79500News Coverage
Upcoming Earnings
Gap Up
ANIP
ANI Pharmaceuticals
3.7646 of 5 stars
$66.50
-1.5%
$78.88
+18.6%
+0.1%$1.44B$614.38M-52.36600Upcoming Earnings

Related Companies and Tools


This page (NASDAQ:SNDL) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners